PAI Partners Agrees to Acquire Majority Stake in Amplitude Surgical

Zydus Lifesciences Acquires 85.6% Stake in Amplitude Surgical

March 11, 2025

Medical Devices

Zydus Lifesciences agreed to acquire an 85.6% controlling stake in French medtech company Amplitude Surgical for €6.25 per share (total consideration €256.8 million) and has completed the block acquisition. Zydus will file a mandatory simplified cash tender offer for the remaining shares at the same price with the aim of securing >90% of capital and implementing a squeeze-out and delisting; Amplitude Surgical is a Valence-based leader in lower-limb orthopaedic implants with ~429 employees and ~€111m revenue (FY Jun 2025).

PAI Partners Acquires Majority Stake in Audiotonix

April 23, 2024

Manufacturing

PAI Partners has agreed to acquire a majority stake in Audiotonix, the UK-headquartered global designer and manufacturer of professional audio mixing consoles and related products. Ardian will retain a minority stake alongside Audiotonix management; the investment will support R&D, product and software development, brand synergies and continued strategic M&A.

PAI Partners to Acquire Majority Stake in Infra Group

July 6, 2023

Infrastructure

PAI Partners has agreed to acquire a majority stake in Infra Group, a Belgium-headquartered multi-disciplinary network infrastructure services provider. The investment will make PAI the largest shareholder alongside existing investors ICG, Andera Partners and the management team, and will support Infra Group's growth strategy to accelerate expansion organically and via complementary acquisitions.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

PAI Partners Acquires 67% Stake in VAMED's European Rehabilitation Business from Fresenius

May 2, 2024

Healthcare Services

PAI Partners will acquire a 67% stake in VAMED's pan‑European rehabilitation business from Fresenius, with Fresenius retaining a 33% stake. The carved‑out business operates 67 clinics across multiple European countries, employs around 10,000 staff and will operate as a standalone rehabilitation platform focused on operational excellence and further investment.

PAI Partners Agrees to Acquire Majority Stake in ECF Group

June 14, 2023

Logistics & Distribution

PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.